ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Mild photothermal/radiation therapy potentiates ferroptosis effect for ablation of breast cancer via MRI/PA imaging guided all-in-one strategy

Zhang, Zhe; Lo, Hsuan; Zhao, Xingyang; Li, Wenya; Wu, Ke; Zeng, Fanchu; Li, Shiying*; Sun, Hongzan*广东省人民医院; 广东省心血管病研究所; 南方医科大学; 中国医科大学
JOURNAL OF NANOBIOTECHNOLOGY2023-5-8DOI: 10.1186/s12951-023-01910-6
5被引11阅读
引用收藏
分享

摘要

Background Nanotheranostics advances anticancer management by providing therapeutic and diagnostic functions, that combine programmed cell death (PCD) initiation and imaging-guided treatment, thus increasing the efficacy of tumor ablation and efficiently fighting against cancer. However, mild photothermal/radiation therapy with imaging-guided precise mediating PCD in solid tumors, involving processes related to apoptosis and ferroptosis, enhanced the effect of breast cancer inhibition is not fully understood.Results Herein, targeted peptide conjugated gold nano cages, iRGD-PEG/AuNCs@FePt NPs ternary metallic nanoparticles (Au@FePt NPs) were designed to achieve photoacoustic imaging (PAI)/Magnetic resonance imaging (MRI) guided synergistic therapy. Tumor-targeting Au@FePt forms reactive oxygen species (ROS), initiated by X-ray-induced dynamic therapy (XDT) in collaboration with photothermal therapy (PTT), inducing ferroptosis-augmented apoptosis to realize effective antitumor therapeutics. The relatively high photothermal conversion ability of Au@FePt increases the temperature in the tumor region and hastens Fenton-like processes to achieve enhanced synergistic therapy. Especially, RNA sequencing found Au@FePt inducting the apoptosis pathway in the transcriptome profile.Conclusion Au@FePt combined XDT/PTT therapy activate apoptosis and ferroptosis related proteins in tumors to achieve breast cancer ablation in vitro and in vivo. PAI/MRI images demonstrated Au@FePt has real-time guidance for monitoring synergistic anti-cancer therapy effect. Therefore, we have provided a multifunctional nanotheranostics modality for tumor inhibition and cancer management with high efficacy and limited side effects.

学科与关键词

关键词
MR/PA imagingTernary metallic nanoparticlesSensitized apoptosisPhotothermal/radiation therapySensitized ferroptosis
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
JOURNAL OF NANOBIOTECHNOLOGY
发表日期
2023-05-08
卷期
第 21 卷, 第 1 期
页码
150
DOI
10.1186/s12951-023-01910-6
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82171910]; Shenyang High Level Innovative Talents Support Program [RC210138]; Outstanding Scientific Fund of Shengjing Hospital

作者

  • Z

    Zhang, Zhe (第一作者)

    china med univ

  • L

    Lo, Hsuan

    guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

查看全部 8 位作者收起作者
  • Z

    Zhao, Xingyang

    guangdong prov peoples hosp · southern med univ

  • L

    Li, Wenya

    guangdong prov peoples hosp · southern med univ

  • W

    Wu, Ke

    china med univ

  • Z

    Zeng, Fanchu

    guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

  • L

    Li, Shiying (通讯)

    guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

  • S

    Sun, Hongzan (通讯)

    china med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417